Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-06

Fariba Jousheghany

Role not yet determined Is this you? Add your title

Also affiliated: University of Arkansas Medical Center (2005–2014); University of Pennsylvania (2003)

14 h-index 42 pubs 707 cited

  • Humans
  • Female
  • Animals
  • Mice
  • Breast Neoplasms
  • Mice, Inbred BALB C
  • Antigens, Tumor-Associated, Carbohydrate
  • Neoplasm Metastasis
  • Lung Neoplasms
  • Proteoglycans
  • Peptides
  • Molecular Mimicry
  • Cancer Vaccines
  • Mammary Neoplasms, Experimental
  • Ligands

Biography and Research Information

OverviewAI-generated summary

Fariba Jousheghany's research focuses on the molecular mechanisms of breast cancer metastasis, particularly the role of chondroitin sulfates. Her work has investigated how these glycosaminoglycans, specifically CSPG4 and CHST11 gene expression, contribute to the formation of surface P-selectin ligands on aggressive breast cancer cells, facilitating metastasis. Jousheghany has also explored the potential of targeting tumor-associated carbohydrate antigens through vaccine development. This includes preclinical studies of carbohydrate mimetic peptide vaccines for breast cancer and melanoma, and a Phase I clinical trial of such a vaccine in stage IV breast cancer patients. Her research network includes collaborators such as Behjatolah Monzavi‐Karbassi and Thomas Kieber‐Emmons at the University of Arkansas for Medical Sciences, with whom she has co-authored multiple publications. Jousheghany's scholarship metrics include an h-index of 14, with 42 publications and 707 citations.

Metrics

  • h-index: 14
  • Publications: 42
  • Citations: 707

Selected Publications

  • Abstract 2908: SR-A antagonism remodels the myeloid population of tumor immune microenvironment, expands CD8-positive T cells, and enhances antitumor efficacy in vivo (2026)
    Cancer Research DOI OpenAlex
  • Class A scavenger receptors promote tumor progression and induce a unique macrophage phenotype in a mouse model of spontaneous breast cancer (2026)
    Journal of Leukocyte Biology DOI OpenAlex
  • Abstract PO5-02-05: Assessing Vaccine-Mediated Cellular Immune Responses in Patients Receiving Combined Vaccine and Chemotherapy Treatment (2024)
    Cancer Research DOI OpenAlex
  • Abstract 3860: Characterizing peripheral immune correlates of tumor response in breast cancer patients immunized with the P10s-PADRE vaccine (2024)
    Cancer Research DOI OpenAlex
  • Abstract 186: Tumor exosome-macrophage interactions: The role of tumor-associated glycans and scavenger receptor class A (2024)
    Cancer Research DOI OpenAlex
  • Abstract 700: Induction of cancer-specific T-cell responses in patients immunized with P10s-PADRE vaccine (2023)
    Cancer Research DOI OpenAlex
  • VT68.2: An Antibody to Chondroitin Sulfate Proteoglycan 4 (CSPG4) Displays Reactivity against a Tumor-Associated Carbohydrate Antigen (2023)
    International Journal of Molecular Sciences 3 citations DOI OpenAlex
  • Abstract P2-14-15: Timing of the immunization defines immune signature of a peptide cancer vaccine combined with Neoadjuvant chemotherapy in HR+ breast cancer patients (2022)
    Cancer Research DOI OpenAlex
  • P10s-PADRE vaccine combined with neoadjuvant chemotherapy in ER-positive breast cancer patients induces humoral and cellular immune responses (2021)
    Oncotarget 11 citations DOI OpenAlex
  • Association of DNA-Methylation Profiles With Immune Responses Elicited in Breast Cancer Patients Immunized With a Carbohydrate-Mimicking Peptide: A Pilot Study (2020)
    Frontiers in Oncology 2 citations DOI OpenAlex
  • Carbohydrate (Chondroitin 4) Sulfotransferase-11-Mediated Induction of Epithelial-Mesenchymal Transition and Generation of Cancer Stem Cells (2020)
    Pharmacology 10 citations DOI OpenAlex
  • Macrophage Class A Scavenger Receptors Bind Tumor‐Associated Carbohydrate Antigens and Promote Breast Cancer Growth and Metastases in Mice (2020)
    The FASEB Journal DOI OpenAlex
  • Abstract P3-09-18: Immunization of breast cancer patients in combination with standard-of-care chemotherapy: Results of a phase Ib clinical trial (2020)
    Cancer Research DOI OpenAlex
  • Carbamate derivatives of colchicine show potent activity towards primary acute lymphoblastic leukemia and primary breast cancer cells—in vitro and ex vivo study (2020)
    Journal of Biochemical and Molecular Toxicology 16 citations DOI OpenAlex
  • Carbamate Derivatives of Colchicine Show Potent Activity toward Primary Acute Lymphoblastic Leukemia and Primary Breast Cancer Cells: <i>In Vitro</i> and <i>Ex Vivo</i> Study (2019)
    The FASEB Journal 1 citation DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

102 Collaborators 19 Institutions 5 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics